{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:50:45Z","timestamp":1793274645419,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Migraine is a severely debilitating disorder that affects millions of people worldwide. Studies have indicated that activation of protease-activated receptor-2 (PAR2) in the dura mater causes headache responses in preclinical models. It is also well known that vasodilators such as nitric oxide (NO) donors can trigger migraine attacks in migraine patients but not controls. In the current study we examined whether activation of PAR2 in the dura causes priming to the NO donor glyceryl trinitrate (GTN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A preclinical behavioral model of migraine was used where stimuli (PAR2 agonists: 2at-LIGRL-NH\n                      <jats:sub>2<\/jats:sub>\n                      (2AT) or neutrophil elastase (NE); and IL-6) were applied to the mouse dura through an injection made at the intersection of the lamdoidal and sagittal sutures on the skull. Following dural injection, periorbital von Frey thresholds and facial grimace responses were measured until their return to baseline. GTN was then given by intraperitoneal injection and periorbital hypersensitivity and facial grimace responses observed until they returned to baseline.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that application of the selective PAR2 agonist 2at-LIGRL-NH\n                      <jats:sub>2<\/jats:sub>\n                      (2AT) onto the dura causes headache-related behavioral responses in WT but not PAR2\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice with no differences between sexes. Additionally, dural PAR2 activation with 2AT caused priming to GTN (1\u00a0mg\/kg) at 14\u00a0days after primary dural stimulation. PAR2\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice showed no priming to GTN. We also tested behavioral responses to the endogenous protease neutrophil elastase, which can cleave and activate PAR2. Dural neutrophil elastase caused both acute responses and priming to GTN in WT but not PAR2\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice. Finally, we show that dural IL-6 causes acute responses and priming to GTN that is identical in WT and PAR2\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice, indicating that IL-6 does not act through PAR2 in this model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results indicate that PAR2 activation in the meninges can cause acute headache behavioral responses and priming to an NO donor, and support further exploration of PAR2 as a novel therapeutic target for migraine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-023-01574-5","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T19:03:48Z","timestamp":1681844628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine model"],"prefix":"10.1186","volume":"24","author":[{"given":"Bianca N.","family":"Mason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayne N.","family":"Hassler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"DeFea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Boitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Vagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Dussor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"issue":"11","key":"1574_CR1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"GBDH Collaborators","year":"2018","unstructured":"Collaborators GBDH (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):954\u2013976","journal-title":"Lancet Neurol"},{"issue":"19","key":"1574_CR2","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M (2020) Migraine. N Engl J Med 383(19):1866\u20131876","journal-title":"N Engl J Med"},{"issue":"10283","key":"1574_CR3","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(20)32342-4","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Buse DC, Ashina H, Pozo-Rosich P, Peres MFP, Lee MJ, Terwindt GM, Halker Singh R, Tassorelli C, Do TP et al (2021) Migraine: integrated approaches to clinical management and emerging treatments. Lancet 397(10283):1505\u20131518","journal-title":"Lancet"},{"key":"1574_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuroscience.2016.06.012","volume":"338","author":"B Jacobs","year":"2016","unstructured":"Jacobs B, Dussor G (2016) Neurovascular contributions to migraine: moving beyond vasodilation. Neuroscience 338:130\u2013144","journal-title":"Neuroscience"},{"key":"1574_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fncel.2019.00136","volume":"13","author":"D Koyuncu Irmak","year":"2019","unstructured":"Koyuncu Irmak D, Kilinc E, Tore F (2019) Shared fate of meningeal mast cells and sensory neurons in migraine. Front Cell Neurosci 13:136","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"1574_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11916-009-0040-y","volume":"13","author":"D Levy","year":"2009","unstructured":"Levy D (2009) Migraine pain, meningeal inflammation, and mast cells. Curr Pain Headache Rep 13(3):237\u2013240","journal-title":"Curr Pain Headache Rep"},{"issue":"13","key":"1574_CR7","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1177\/0333102418771350","volume":"39","author":"D Levy","year":"2019","unstructured":"Levy D, Labastida-Ramirez A, MaassenVanDenBrink A (2019) Current understanding of meningeal and cerebral vascular function underlying migraine headache. Cephalalgia 39(13):1606\u20131622","journal-title":"Cephalalgia"},{"key":"1574_CR8","doi-asserted-by":"crossref","unstructured":"Phebus LA, Johnson KW: Dural inflammation model of migraine pain. Curr Protoc Neurosci 2001, Chapter 9:Unit9 1.","DOI":"10.1002\/0471142301.ns0901s06"},{"issue":"5","key":"1574_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0165-6147(94)90075-2","volume":"15","author":"J Olesen","year":"1994","unstructured":"Olesen J, Thomsen LL, Iversen H (1994) Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15(5):149\u2013153","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"1574_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrneurol.2017.137","volume":"13","author":"M Ashina","year":"2017","unstructured":"Ashina M, Hansen JM, Dunga BOA, Olesen J (2017) Human models of migraine - short-term pain for long-term gain. Nat Rev Neurol 13(12):713\u2013724","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"1574_CR11","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1097\/j.pain.0000000000001894","volume":"161","author":"GLJ Onderwater","year":"2020","unstructured":"Onderwater GLJ, Dool J, Ferrari MD, Terwindt GM (2020) Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control study. Pain 161(9):2058\u20132067","journal-title":"Pain"},{"key":"1574_CR12","doi-asserted-by":"crossref","unstructured":"Christiansen I, Thomsen LL, Daugaard D, Ulrich V, Olesen J: Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia 1999, 19(7):660\u2013667; discussion 626.","DOI":"10.1046\/j.1468-2982.1999.019007660.x"},{"issue":"2","key":"1574_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s13311-018-0614-7","volume":"15","author":"AA Pradhan","year":"2018","unstructured":"Pradhan AA, Bertels Z, Akerman S (2018) Targeted nitric oxide synthase inhibitors for migraine. Neurotherapeutics 15(2):391\u2013401","journal-title":"Neurotherapeutics"},{"issue":"4","key":"1574_CR14","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/sj.jid.5700169","volume":"126","author":"C Moormann","year":"2006","unstructured":"Moormann C, Artuc M, Pohl E, Varga G, Buddenkotte J, Vergnolle N, Brehler R, Henz BM, Schneider SW, Luger TA et al (2006) Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J Invest Dermatol 126(4):746\u2013755","journal-title":"J Invest Dermatol"},{"key":"1574_CR15","doi-asserted-by":"crossref","unstructured":"Hassler SN, Kume M, Mwirigi JM, Ahmad A, Shiers S, Wangzhou A, Ray PR, Belugin SN, Naik DK, Burton MD et al (2020) The cellular basis of protease-activated receptor 2-evoked mechanical and affective pain. JCI Insight 5(11):e137393","DOI":"10.1172\/jci.insight.137393"},{"issue":"3","key":"1574_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.33549\/physiolres.933269","volume":"65","author":"P Mrozkova","year":"2016","unstructured":"Mrozkova P, Palecek J, Spicarova D (2016) The role of protease-activated receptor type 2 in nociceptive signaling and pain. Physiol Res 65(3):357\u2013367","journal-title":"Physiol Res"},{"issue":"2","key":"1574_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1113\/EP086092","volume":"102","author":"N Fujii","year":"2017","unstructured":"Fujii N, McNeely BD, Zhang SY, Abdellaoui YC, Danquah MO, Kenny GP (2017) Activation of protease-activated receptor 2 mediates cutaneous vasodilatation but not sweating: roles of nitric oxide synthase and cyclo-oxygenase. Exp Physiol 102(2):265\u2013272","journal-title":"Exp Physiol"},{"issue":"3","key":"1574_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1468-2982.2007.01523.x","volume":"28","author":"XC Zhang","year":"2008","unstructured":"Zhang XC, Levy D (2008) Modulation of meningeal nociceptors mechanosensitivity by peripheral proteinase-activated receptor-2: the role of mast cells. Cephalalgia 28(3):276\u2013284","journal-title":"Cephalalgia"},{"key":"1574_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12959-019-0194-8","volume":"17","author":"DM Heuberger","year":"2019","unstructured":"Heuberger DM, Schuepbach RA (2019) Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. Thromb J 17:4","journal-title":"Thromb J"},{"issue":"6","key":"1574_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2174\/1568026054367601","volume":"5","author":"N Cenac","year":"2005","unstructured":"Cenac N, Vergnolle N (2005) Proteases and protease-activated receptors (PARs): novel signals for pain. Curr Top Med Chem 5(6):569\u2013576","journal-title":"Curr Top Med Chem"},{"issue":"28","key":"1574_CR21","doi-asserted-by":"publisher","first-page":"24638","DOI":"10.1074\/jbc.M110.201988","volume":"286","author":"R Ramachandran","year":"2011","unstructured":"Ramachandran R, Mihara K, Chung H, Renaux B, Lau CS, Muruve DA, DeFea KA, Bouvier M, Hollenberg MD (2011) Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2). J Biol Chem 286(28):24638\u201324648","journal-title":"J Biol Chem"},{"issue":"22","key":"1574_CR22","doi-asserted-by":"publisher","first-page":"13875","DOI":"10.1074\/jbc.M115.642736","volume":"290","author":"P Zhao","year":"2015","unstructured":"Zhao P, Lieu T, Barlow N, Sostegni S, Haerteis S, Korbmacher C, Liedtke W, Jimenez-Vargas NN, Vanner SJ, Bunnett NW (2015) Neutrophil elastase activates protease-activated receptor-2 (PAR2) and transient receptor potential vanilloid 4 (TRPV4) to cause inflammation and pain. J Biol Chem 290(22):13875\u201313887","journal-title":"J Biol Chem"},{"issue":"1","key":"1574_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/0333102418779548","volume":"39","author":"SN Hassler","year":"2019","unstructured":"Hassler SN, Ahmad FB, Burgos-Vega CC, Boitano S, Vagner J, Price TJ, Dussor G (2019) Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice. Cephalalgia 39(1):111\u2013122","journal-title":"Cephalalgia"},{"issue":"6","key":"1574_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1526-4610.2010.01679.x","volume":"50","author":"DK Bhatt","year":"2010","unstructured":"Bhatt DK, Ploug KB, Ramachandran R, Olesen J, Gupta S (2010) Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the dural artery. Headache 50(6):1017\u20131030","journal-title":"Headache"},{"issue":"4","key":"1574_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00011-022-01551-9","volume":"71","author":"A Barra","year":"2022","unstructured":"Barra A, Brasil AF, Ferreira TL, Fernandes-Braga W, Marconato DG, Faria-Pinto P, Alvarez-Leite JI, Dos Santos Aggum Capettini L, Klein A (2022) Protease-activated receptor 2 enhances innate and inflammatory mechanisms induced by lipopolysaccharide in macrophages from C57BL\/6 mice. Inflamm Res 71(4):439\u2013448","journal-title":"Inflamm Res"},{"issue":"6","key":"1574_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1177\/1535370215622584","volume":"241","author":"LC Tillery","year":"2016","unstructured":"Tillery LC, Epperson TA, Eguchi S, Motley ED (2016) Featured article: differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells. Exp Biol Med (Maywood) 241(6):569\u2013580","journal-title":"Exp Biol Med (Maywood)"},{"issue":"5","key":"1574_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/j.pain.0000000000000125","volume":"156","author":"DV Tillu","year":"2015","unstructured":"Tillu DV, Hassler SN, Burgos-Vega CC, Quinn TL, Sorge RE, Dussor G, Boitano S, Vagner J, Price TJ (2015) Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state. Pain 156(5):859\u2013867","journal-title":"Pain"},{"key":"1574_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1744-8069-8-6","volume":"8","author":"J Yan","year":"2012","unstructured":"Yan J, Melemedjian OK, Price TJ, Dussor G (2012) Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6). Mol Pain 8:6","journal-title":"Mol Pain"},{"key":"1574_CR29","doi-asserted-by":"crossref","unstructured":"Burgos-Vega CC, Quigley LD, Trevisan Dos Santos G, Yan F, Asiedu M, Jacobs B, Motina M, Safdar N, Yousuf H, Avona A et al: Non-invasive dural stimulation in mice: a novel preclinical model of migraine. Cephalalgia 2018:333102418779557.","DOI":"10.1177\/0333102418779557"},{"key":"1574_CR30","doi-asserted-by":"crossref","unstructured":"Mason BN, Avona A, Lackovic J, Dussor G: - Dural Stimulation and periorbital von Frey testing in mice as a preclinical model of headache.\u00a0J Vis Exp.\u00a02021(- 173).","DOI":"10.3791\/62867"},{"issue":"1","key":"1574_CR31","first-page":"42","volume":"51","author":"LC Matsumiya","year":"2012","unstructured":"Matsumiya LC, Sorge RE, Sotocinal SG, Tabaka JM, Wieskopf JS, Zaloum A, King OD, Mogil JS (2012) Using the Mouse Grimace Scale to reevaluate the efficacy of postoperative analgesics in laboratory mice. J Am Assoc Lab Anim Sci 51(1):42\u201349","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"6","key":"1574_CR32","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/ana.26070","volume":"89","author":"A Avona","year":"2021","unstructured":"Avona A, Mason BN, Burgos-Vega C, Hovhannisyan AH, Belugin SN, Mecklenburg J, Goffin V, Wajahat N, Price TJ, Akopian AN et al (2021) Meningeal CGRP-Prolactin Interaction Evokes Female-Specific Migraine Behavior. Ann Neurol 89(6):1129\u20131144","journal-title":"Ann Neurol"},{"issue":"21","key":"1574_CR33","doi-asserted-by":"publisher","first-page":"19076","DOI":"10.1074\/jbc.M110.185264","volume":"286","author":"AN Flynn","year":"2011","unstructured":"Flynn AN, Tillu DV, Asiedu MN, Hoffman J, Vagner J, Price TJ, Boitano S (2011) The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH2 and 6-aminonicotinyl-LIGRL-NH2 stimulate multiple signaling pathways to induce physiological responses in vitro and in vivo. J Biol Chem 286(21):19076\u201319088","journal-title":"J Biol Chem"},{"key":"1574_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099140","volume":"9","author":"S Boitano","year":"2014","unstructured":"Boitano S, Hoffman J, Tillu D, Asiedu M, Zhang Z, Sherwood C, Wang Y, Dong X, Price T, Vagner J (2014) Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tethering. PLoS ONE 9:e99140","journal-title":"PLoS ONE"},{"issue":"1","key":"1574_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF01534383","volume":"19","author":"U Bank","year":"1995","unstructured":"Bank U, Reinhold D, Kunz D, Schulz HU, Schneemilch C, Brandt W, Ansorge S (1995) Effects of interleukin-6 (IL-6) and transforming growth factor-beta (TGF-beta) on neutrophil elastase release. Inflammation 19(1):83\u201399","journal-title":"Inflammation"},{"issue":"8","key":"1574_CR36","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/00001756-199308000-00008","volume":"4","author":"J Olesen","year":"1993","unstructured":"Olesen J, Iversen HK, Thomsen LL (1993) Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. NeuroReport 4(8):1027\u20131030","journal-title":"NeuroReport"},{"issue":"5","key":"1574_CR37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/sj.bjp.0702634","volume":"127","author":"N Vergnolle","year":"1999","unstructured":"Vergnolle N, Hollenberg MD, Sharkey KA, Wallace JL (1999) Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol 127(5):1083\u20131090","journal-title":"Br J Pharmacol"},{"issue":"16","key":"1574_CR38","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.2174\/1389450117666151209115232","volume":"17","author":"TJ Bushell","year":"2016","unstructured":"Bushell TJ, Cunningham MR, McIntosh KA, Moudio S, Plevin R (2016) Protease-activated receptor 2: are common functions in glial and immune cells linked to inflammation-related CNS disorders? Curr Drug Targets 17(16):1861\u20131870","journal-title":"Curr Drug Targets"},{"issue":"1","key":"1574_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0333102416637832","volume":"37","author":"LA McIlvried","year":"2017","unstructured":"McIlvried LA, Cruz JA, Borghesi LA, Gold MS (2017) Sex-, stress-, and sympathetic post-ganglionic-dependent changes in identity and proportions of immune cells in the dura. Cephalalgia 37(1):36\u201348","journal-title":"Cephalalgia"},{"issue":"1","key":"1574_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/bja\/aet127","volume":"111","author":"EJ Bartley","year":"2013","unstructured":"Bartley EJ, Fillingim RB (2013) Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth 111(1):52\u201358","journal-title":"Br J Anaesth"},{"issue":"6","key":"1574_CR41","doi-asserted-by":"publisher","first-page":"490","DOI":"10.30802\/AALAS-CM-19-000066","volume":"69","author":"JC Smith","year":"2019","unstructured":"Smith JC (2019) A review of strain and sex differences in response to pain and analgesia in mice. Comp Med 69(6):490\u2013500","journal-title":"Comp Med"},{"issue":"6","key":"1574_CR42","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/jnr.23841","volume":"95","author":"RE Sorge","year":"2017","unstructured":"Sorge RE, Totsch SK (2017) Sex differences in pain. J Neurosci Res 95(6):1271\u20131281","journal-title":"J Neurosci Res"},{"issue":"1","key":"1574_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13293-019-0262-6","volume":"10","author":"J Noguerol","year":"2019","unstructured":"Noguerol J, Roustan PJ, N\u2019Taye M, Delcombel L, Rolland C, Guiraud L, Sagnat D, Edir A, Bonnart C, Denadai-Souza A et al (2019) Sexual dimorphism in PAR2-dependent regulation of primitive colonic cells. Biol Sex Differ 10(1):47","journal-title":"Biol Sex Differ"},{"issue":"2","key":"1574_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1526-4610.2006.00337.x","volume":"46","author":"P Sarchielli","year":"2006","unstructured":"Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P (2006) Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46(2):200\u2013207","journal-title":"Headache"},{"issue":"1\u20132","key":"1574_CR45","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jneuroim.2005.10.005","volume":"171","author":"I Fidan","year":"2006","unstructured":"Fidan I, Yuksel S, Ymir T, Irkec C, Aksakal FN (2006) The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 171(1\u20132):184\u2013188","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1574_CR46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1084\/jem.142.2.361","volume":"142","author":"Z Werb","year":"1975","unstructured":"Werb Z, Gordon S (1975) Elastase secretion by stimulated macrophages.\u00a0characterization and regulation. J Exp Med 142(2):361\u2013377","journal-title":"J Exp Med"},{"issue":"3","key":"1574_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF00914396","volume":"13","author":"HL Meier","year":"1989","unstructured":"Meier HL, Schulman ES, Heck LW, MacGlashan D, Newball HH, Kaplan AP (1989) Release of elastase from purified human lung mast cells and basophils.\u00a0identification as a Hageman factor cleaving enzyme. Inflammation 13(3):295\u2013308","journal-title":"Inflammation"},{"issue":"6","key":"1574_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000327009","volume":"48","author":"T Hennig","year":"2011","unstructured":"Hennig T, Mogensen C, Kirsch J, Pohl U, Gloe T (2011) Shear stress induces the release of an endothelial elastase: role in integrin alpha(v)beta(3)-mediated FGF-2 release. J Vasc Res 48(6):453\u2013464","journal-title":"J Vasc Res"},{"issue":"3","key":"1574_CR49","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.ajpath.2011.05.051","volume":"179","author":"YM Kim","year":"2011","unstructured":"Kim YM, Haghighat L, Spiekerkoetter E, Sawada H, Alvira CM, Wang L, Acharya S, Rodriguez-Colon G, Orton A, Zhao M et al (2011) Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions. Am J Pathol 179(3):1560\u20131572","journal-title":"Am J Pathol"},{"issue":"12","key":"1574_CR50","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1093\/humrep\/dei255","volume":"20","author":"Y Hirota","year":"2005","unstructured":"Hirota Y, Osuga Y, Hirata T, Harada M, Morimoto C, Yoshino O, Koga K, Yano T, Tsutsumi O, Taketani Y (2005) Activation of protease-activated receptor 2 stimulates proliferation and interleukin (IL)-6 and IL-8 secretion of endometriotic stromal cells. Hum Reprod 20(12):3547\u20133553","journal-title":"Hum Reprod"},{"issue":"2","key":"1574_CR51","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1046\/j.0022-202x.2001.01658.x","volume":"118","author":"VM Shpacovitch","year":"2002","unstructured":"Shpacovitch VM, Brzoska T, Buddenkotte J, Stroh C, Sommerhoff CP, Ansel JC, Schulze-Osthoff K, Bunnett NW, Luger TA, Steinhoff M (2002) Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J Invest Dermatol 118(2):380\u2013385","journal-title":"J Invest Dermatol"},{"issue":"6","key":"1574_CR52","doi-asserted-by":"publisher","first-page":"F737","DOI":"10.1152\/ajprenal.00540.2012","volume":"304","author":"DA Vesey","year":"2013","unstructured":"Vesey DA, Suen JY, Seow V, Lohman RJ, Liu L, Gobe GC, Johnson DW, Fairlie DP (2013) PAR2-induced inflammatory responses in human kidney tubular epithelial cells. Am J Physiol Renal Physiol 304(6):F737-750","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01574-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-023-01574-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01574-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T19:03:52Z","timestamp":1681844632000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-023-01574-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1186\/s10194-023-01574-5","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"28 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments and procedures were performed in accordance with the guidelines recommended by the National Institute of Health and the International Association for the study of Pain. Experiments and procedures were additionally approved by the Institutional Animal Care and Use Committee at University of Texas at Dallas (protocol 14\u201305).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KD, SB, JV, TP, and GD are co-founders of Parmedics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}